CervoMed Valuation
| CRVO Stock | 7.41 0.16 2.11% |
At this time, the firm appears to be undervalued. CervoMed shows a prevailing Real Value of USD9.35 per share. The current price of the firm is USD7.41. Our model approximates the value of CervoMed from analyzing the firm fundamentals such as Return On Equity of -0.93, profit margin of (2.01) %, and Current Valuation of 29.24 M as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting CervoMed's valuation include:
Undervalued
Today
Please note that CervoMed's price fluctuation is slightly risky at this time. Calculation of the real value of CervoMed is based on 3 months time horizon. Increasing CervoMed's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since CervoMed is currently traded on the exchange, buyers and sellers on that exchange determine the market value of CervoMed Stock. However, CervoMed's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 7.41 | Real 9.35 | Target 15.83 | Hype 7.56 | Naive 8.54 |
The intrinsic value of CervoMed's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence CervoMed's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of CervoMed helps investors to forecast how CervoMed stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of CervoMed more accurately as focusing exclusively on CervoMed's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use CervoMed's intrinsic value based on its ongoing forecasts of CervoMed's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against CervoMed's closest peers.
CervoMed Cash |
|
CervoMed Valuation Trend
Knowing CervoMed's actual value is paramount for traders when making sound investment determinations. Using both CervoMed's enterprise value as well as its market capitalization is the best way to estimate the value of the company and is usually enough for investors to make market timing decisions.
CervoMed Total Value Analysis
CervoMed is currently anticipated to have valuation of 29.24 M with market capitalization of 64.49 M, debt of 3.88 M, and cash on hands of . Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the CervoMed fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
29.24 M | 64.49 M | 3.88 M |
CervoMed Investor Information
About 33.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 1.86. Some equities with similar Price to Book (P/B) outperform the market in the long run. CervoMed recorded a loss per share of 2.17. The entity last dividend was issued on the 14th of December 2018. The firm had 2:3 split on the 17th of August 2023. Based on the measurements of operating efficiency obtained from CervoMed's historical financial statements, CervoMed may be sliding down financialy. It has an above-average odds of going through some form of financial crisis next quarter.CervoMed Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. CervoMed has an asset utilization ratio of 22.6 percent. This suggests that the Company is making USD0.23 for each dollar of assets. An increasing asset utilization means that CervoMed is more efficient with each dollar of assets it utilizes for everyday operations.CervoMed Ownership Allocation
The market capitalization of CervoMed is USD64.49 Million. CervoMed retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Note, that even with negative profits, if the true value of the firm is larger than the current market value, you may still be able to generate positive returns on investment in this company.CervoMed Profitability Analysis
The company reported the previous year's revenue of 9.74 M. Net Loss for the year was (16.29 M) with loss before overhead, payroll, taxes, and interest of (11.51 M).About CervoMed Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of CervoMed. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of CervoMed based exclusively on its fundamental and basic technical indicators. By analyzing CervoMed's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of CervoMed's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of CervoMed. We calculate exposure to CervoMed's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of CervoMed's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | -9.1 M | -8.6 M | |
| Pretax Profit Margin | (1.67) | (1.76) | |
| Operating Profit Margin | (1.87) | (1.97) | |
| Net Loss | (1.67) | (1.76) | |
| Gross Profit Margin | (0.21) | (0.22) |
CervoMed Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 8.1 M |
CervoMed Current Valuation Indicators
CervoMed's valuation analysis is a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final CervoMed's valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as CervoMed, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use CervoMed's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes CervoMed's worth.When determining whether CervoMed offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of CervoMed's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Cervomed Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Cervomed Stock: Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CervoMed. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. To learn how to invest in CervoMed Stock, please use our How to Invest in CervoMed guide.You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CervoMed. If investors know CervoMed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about CervoMed listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.17) | Revenue Per Share | Quarterly Revenue Growth (0.18) | Return On Assets | Return On Equity |
The market value of CervoMed is measured differently than its book value, which is the value of CervoMed that is recorded on the company's balance sheet. Investors also form their own opinion of CervoMed's value that differs from its market value or its book value, called intrinsic value, which is CervoMed's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because CervoMed's market value can be influenced by many factors that don't directly affect CervoMed's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between CervoMed's value and its price as these two are different measures arrived at by different means. Investors typically determine if CervoMed is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CervoMed's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.